{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-096322","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2025-10-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.935170+00:00","generated_at":"2026-05-17T04:32:58.691347+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Oramed receives $13M from Scilex in first tranche of warrant repurchase","bullets":["Scilex repurchased warrants for 3,130,000 shares of Scilex common stock for $13,000,000 on Sept 30, 2025.","Scilex retains option to repurchase remaining 3,370,000 warrants for $14,000,000 by Dec 31, 2025.","Total aggregate purchase price for both tranches is $27,000,000; original option agreement was filed July 23, 2025.","Warrants repurchased have an exercise price of $0.01 per share of Scilex common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-096322","json":"https://secwatch.observer/filing/0001213900-25-096322.json","markdown":"https://secwatch.observer/filing/0001213900-25-096322.md","text":"https://secwatch.observer/filing/0001213900-25-096322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/0001213900-25-096322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025096322/ea0260371-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:32:58.691347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}